MAPT and tauopathy: Another zebrafish tauopathy model from the Rubinsztein group successfully confirmed the pathogenicity of Tau A152T variant (TauA125T) as a risk factor for FTD and AD by generating a novel transgenic line overexpressing this human Tau variant using the Gal4/UAS system [170].